This article has been updated with additional comment from the company's earnings conference call.

NEW YORK (GenomeWeb) – OpGen reported after the close of the market on Tuesday that its second quarter revenues dropped 42 percent year over year.

For the three months ended June 30, the firm reported total revenues of $703,210, down from $1.2 million in Q2 2016. Product sales fell to $681,127 from $1.0 million in the year-ago quarter, while lab services revenues fell to $15,850 from $29,674, and collaboration revenues sank to $6,233 from $125,000.

Get the full story

This story is free
for registered users

Registering provides access to this and other free content.

Register now.

Already have an account?
Login Now.

NPR reports that Turkish high school students will no longer study evolution.

Researchers report they sequenced and identified plant species in an "al fresco" laboratory.

An Australian team searches for genetic alterations linked to depression in hopes of developing personalized treatments, the Sydney Morning Herald reports.

In PNAS this week: host contributors to typhoid fever risk, effects of obesity-related variants near TMEM18, and more.